The California Institute for Biomedical Research and JDRF announced a partnership today to apply Calibr’s drug discovery expertise to type 1 diabetes research projects in collaboration with academic investigators from JDRF’s network.

See the original article here:
Calibr, JDRF partner to research on promising type 1 diabetes therapeutic targets

Scroll to Top